What Do Clinical Evaluation Documents Typically Focus On?

Clinical evaluation documentation typically focuses on the device's intended use, target patient population, performance claims, clinical benefit, benefit-risk profile, comparison with equivalent or similar devices, clinical literature, existing clinical experience with the device or its equivalents, adverse events, performance verification, and post-market data. The objective is not to accumulate literature for its own sake, but to demonstrate that the device achieves acceptable safety and effectiveness for its intended purpose — and that the clinical evidence is consistent with the labelling, risk management file, technical documentation and product claims.

Key Summary

Clinical evaluation documentation usually addresses the following elements:

• Intended use and indications for use
• Target patient population and contraindications
• Performance claims, including clinical performance claims
• Clinical benefit and the benefit-risk determination
• Comparison with equivalent or similar marketed devices
• Clinical literature and systematic literature search results
• Existing clinical experience and market history
• Adverse events, complaints and vigilance data
• Performance verification and validation evidence
• Post-market clinical follow-up and post-market surveillance data

The decisive question is whether the evidence set supports acceptable safety and effectiveness for the intended use, and whether it aligns with the label, instructions for use, risk management documentation, technical file and any marketing claims made by the manufacturer.

Assessment Logic

Before determining the submission timeline, manufacturers should first confirm the device's classification and attributes, its risk level, the applicable regulatory pathway in each target market, and the gaps in the existing documentation set. Requirements differ between countries with respect to the depth of clinical evidence required, the language of labelling, the need for a local authorized representative or license holder, and post-market obligations. A single fixed checklist cannot be applied across all markets.

Documentation Priorities

Documentation preparation should focus on verifying internal consistency across the following items:

• Device description, intended use and model or specification variants
• Risk management documentation
• Performance verification and validation data
• Clinical evidence, or the clinical evaluation report supporting equivalence or exemption from clinical investigation
• Labelling and instructions for use
• Quality management system certification and evidence of conformity
• Authorization documents, declarations and local representation arrangements
• Post-market surveillance and post-market clinical follow-up plans

Common Pitfalls

A frequent mistake is to focus narrowly on whether a submission can be filed, while overlooking classification decisions, documentation consistency, product claims, post-market responsibilities and country-specific localization requirements. The earlier a gap assessment is performed in the project lifecycle, the lower the risk of deficiency letters, supplementary submissions and rework later on.

AIMEILI Perspective

AIMEILI recommends that manufacturers assess this question at the project initiation stage rather than addressing it shortly before submission. A more robust approach is to first complete the device classification analysis, documentation gap assessment, prioritization of target markets, appointment of local responsible parties, and post-market maintenance planning — and then translate these into an executable registration plan.

Continued Reading

• Do all medical devices require clinical trials for overseas registration?
• Can a device be sold immediately after the registration certificate is obtained?
• What should be considered when selling a medical device software app on EU online platforms?
• When must a change notification be submitted for a medical device modification?
• How should performance evaluation documentation be prepared for overseas IVD registration?
• How should cybersecurity documentation for medical devices be prepared in advance?
• What documentation is commonly required for international medical device registration?
• What should companies prepare before TGA medical device registration in Australia?

Content Review and Scope of Application

Content author: AIMEILI Regulatory Editorial Team
Professional review: AIMEILI Medical Device International Registration Project Team
Source principles: Priority is given to official regulatory authorities, international organizations, standards bodies and publicly available regulatory materials; industry media and project experience are used only as supporting references.
Scope of application: This article is intended for preliminary understanding, documentation preparation and project planning. It does not replace the formal requirements of the target country's regulatory authority, testing conclusions or legal advice.